In partnership with
How Jennifer Aniston’s LolaVie brand grew sales 40% with CTV ads
For its first CTV campaign, Jennifer Aniston’s DTC haircare brand LolaVie had a few non-negotiables. The campaign had to be simple. It had to demonstrate measurable impact. And it had to be full-funnel.
LolaVie used Roku Ads Manager to test and optimize creatives — reaching millions of potential customers at all stages of their purchase journeys. Roku Ads Manager helped the brand convey LolaVie’s playful voice while helping drive omnichannel sales across both ecommerce and retail touchpoints.
The campaign included an Action Ad overlay that let viewers shop directly from their TVs by clicking OK on their Roku remote. This guided them to the website to buy LolaVie products.
Discover how Roku Ads Manager helped LolaVie drive big sales and customer growth with self-serve TV ads.
The DTC beauty category is crowded. To break through, Jennifer Aniston’s brand LolaVie, worked with Roku Ads Manager to easily set up, test, and optimize CTV ad creatives. The campaign helped drive a big lift in sales and customer growth, helping LolaVie break through in the crowded beauty category.
Good morning. Meta and Tesla reported last night, so the open is about how their stocks react, with weekly jobless claims due at 8:30 a.m. ET.
The Market Gauge
Stocks rose across the board Wednesday. The S&P 500 gained 0.58% to 7,757.17, the Nasdaq jumped 1.05% to 26,702.86, and the Dow added 360.21 points, or 0.69%, to 52,856.09. SpaceX led the tech charge, rising 7.8% after posting its first quarterly profit as a public company, with revenue up 161% to $14.6 billion. Super Micro Computer surged after raising its sales outlook, and chip stocks rallied about 1.9% as a group. Netflix fell after a weak forecast. The 10-year Treasury yield rose to about 5.15%, and U.S. crude settled near $97 a barrel.
IBD's read: the Nasdaq climbed back above its 50-day moving average, so all three major indexes are now above that line. IBD sees room for some careful, small buys but says to let the market draw you in, and it calls the reaction to Meta's report the key for Thursday's session. Keep building watchlists.
Beginner note: a few giant stocks can carry an index. The Nasdaq rose 1.05%, but an equal-weight Nasdaq-100 fund, which gives every stock the same say, rose only 0.7% and is still below its own 50-day line. When the average stock lags the index, the rally is narrower than the headline number suggests.
On today's calendar
Weekly jobless claims, 8:30 a.m. ET. This counts how many people filed for unemployment benefits for the first time last week. Low numbers mean employers are holding on to workers; a sudden jump can be an early sign the job market is cooling.
Meta Platforms reacts at the open. Meta beat profit estimates, excluding a large legal charge, and raised the low end of its 2026 spending plan for AI data centers. It also announced a two-for-one stock split. A split gives you two shares for each one you own at half the price, so the value of your stake does not change; it only makes each share cheaper to buy. Shares rose modestly in late trading.
Tesla reacts at the open. Tesla beat profit estimates while revenue just missed. It spent less on new factories and equipment than in the prior quarter and cut its full-year spending plan, which helped it report positive free cash flow, meaning more cash came in than went out. Shares slipped in late trading.
Other late reports. IBM and Lam Research fell in extended trading, while CSX rose and Texas Instruments edged higher. First-hour moves after earnings can reverse, so watching is often wiser than reacting.
Lockheed Martin earnings, before the open (call 8:30 a.m. ET). The defense contractor's results are a read on government weapons spending.
On the radar: Cardinal Health
$CAH ( ▼ 0.71% ) Cardinal Health is one of the largest distributors of drugs and medical supplies in the U.S., moving products from manufacturers to pharmacies and hospitals. The stock closed Wednesday at 257.46, down 0.03%, after touching 259.02 intraday, a new 52-week high. That intraday high cleared a cup-base buy point of 258.30, per IBD, but the stock closed about 0.3% below it, on volume about 16% below average. IBD notes its relative strength line, which compares the stock with the S&P 500, is at a new high. Cardinal Health reports results on Nov. 5.
Why it's worth watching: when the relative strength line hits a new high before the price breaks out, the stock is already beating the market while it is still inside its base. That is often a mark of a leader. Still, the breakout is not confirmed: a strong one closes above the buy point on volume well above average, and Wednesday's move did neither.
How useful was today's Before the Bell?
ONE FOR THE ROAD
Do you check how the average stock is doing, or just the big index numbers?
Educational content only. Not financial advice. Past performance does not predict future results. Read the full financial disclosure.
Invest Alongside a $12B Owner/Operator
Choose individual real estate investments backed by a $12B owner/operator that invests 20%+ alongside individual LPs in every offering.
Accredited Investors only. $100k minimum investment.
This communication is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Any such offer or solicitation will be made exclusively through the definitive offering documents. All investments involve risk of loss, including the potential loss of principal. Past performance is not a guarantee of future results. Any targeted returns or projections are forward-looking statements, are based on current assumptions, and are not guarantees of future performance. Actual results may differ materially.